Table 2 Definitions of epitopic sites (ES) seen by Abs and Nbs.
From: SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
ES | RBD residue (range) | Amino acid sequence | Structural feature | ASA (Ă…2) | Abs (H chain) (%) | Nbs (%) |
---|---|---|---|---|---|---|
1 | 339–341 | GEV | α-helix | 155 | 0.78 | 0.16 |
2 | 343–349 | NATRFAS | loop | 455 | 4.07 | 2.83 |
3 | 351–357 | YAWNRKR | 310 ->β-strand | 410 | 2.60 | 3.76 |
4 | 368–374 | LYNSASF | α-helix->loop | 469 | 3.17 | 7.03 |
5 | 375–380 | STFKCY | β-strand | 287 | 2.90 | 6.97 |
6 | 381–386 | GVSPTK | Loop->310 | 381 | 2.49 | 5.50 |
7 | 403–409 | RGDEVRQ | 310 | 321 | 2.76 | 4.68 |
8 | 411–417 | APGQTGK | loop | 342 | 4.91 | 2.78 |
9 | 420–428 | DYNYKLPDD | α-helix->loop | 371 | 3.24 | 1.69 |
10 | 437–443 | NSNNLDS | β-strand->α-helix | 378 | 3.59 | 1.47 |
11 | 444–449 | KVGGNY | loop/strand | 457 | 7.10 | 8.39 |
12 | 450–454 | NYLYR | β-strand | 194 | 4.57 | 5.72 |
13 | 455–460 | LFRKSN | loop | 448 | 9.98 | 4.25 |
14 | 462–467 | KPFERD | loop | 470 | 1.28 | 1.31 |
15 | 468–472 | ISTEI | loop | 384 | 2.44 | 4.47 |
16 | 473–479 | YQAGSTP | β-strand->loop | 466 | 9.34 | 0.71 |
17 | 481–484 | NGVE | loop | 404 | 4.36 | 5.28 |
18 | 485–487 | GFN | loop | 275 | 7.06 | 3.65 |
19 | 488–491 | CYFP | β-strand->loop | 181 | 5.98 | 5.88 |
20 | 492–496 | LQSYG | β-strand | 126 | 7.15 | 9.69 |
21 | 497–502 | FQPTNG | loop | 307 | 3.38 | 2.94 |
22 | 503–509 | VGYQPYR | 310->β-strand | 253 | 2.42 | 4.14 |
23 | 516–520 | ELLHA | loop | 548 | 0.44 | 1.20 |